Contact this trialFirst, we need to learn more about you.
Cancer Vaccine
Vaccine for Respiratory Syncytial Virus
Recruiting2 awardsPhase 3
Orlando, Florida
This trial aims to test a new vaccine for respiratory syncytial virus in adults aged 18-49 years who are at risk for the disease, compared to older adults aged 60 years and above
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service